SEI Medical Public Co., Ltd.

SEI Medical Public Co., Ltd.

1.97
THB
-0.03
(-1.50%)
0.18EPS
9.14P/E
282.20MMarket Cap
SEI Medical Public Co., Ltd.
SET:SEI.R
(Stock Exchange of Thailand)

Recent

price

1.97

P/E

ratio

9.14

div

yld

- -

ROIC.AI

2022
2023
2024
2025
TTM
THB
1.89
2.32
3.31
2.65
2.42
Revenue per Share
0.11
0.13
0.39
0.27
0.18
Basic EPS, GAAP
0.19
-0.18
0.3
0.21
-0.39
Free Cash Flow per Basic Share
0.35
0.44
- -
0.12
- -
Dividend per Share
0.17
0.47
1.66
1.84
1.81
Book Value per Share
0.15
0.45
1.65
1.81
1.79
Tangible Book Value per Share
170
170
134
170
170
Basic Weighted Avg Shares
321
394
444
450
412
Sales/Revenue/Turnover
7.26
7.61
14.69
12.79
9.71
Operating Margin (%)
17
15
13
15
17
Depreciation Expense
18
22
52
46
31
Net Income, GAAP
20.91
20.43
20.01
20.47
20.94
Effective Tax Rate (%)
5.57
5.56
11.76
10.34
7.5
Profit Margin (%)
1
57
256
238
207
Working Capital
- -
23
18
12
9
LT Debt
28
79
283
312
308
Total Equity
- -
14.73
18.02
11.43
7.56
Return on Invested Capital (%)
- -
15.22
18.87
12.17
7.92
Return on Capital (%)
- -
40.65
28.85
15.63
10.3
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
89
100
125
LT Borrowings
6
5
4
LT Finance Leases
6
6
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
170
170
170
Market Capitalization
371
350
282

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
419
401
405
Cash, Cash Equivalents & STI
177
147
127
Accounts Receivable, Net
88
98
107
Inventories
140
147
163
Total Current Liabilities
181
180
198
Payables & Accruals
68
53
48
ST Debt
89
100
125
Deferred Revenue
12
13
13

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
10.29%
Free Cash Flow
- -
- -
-10.22%
Net Income, GAAP
- -
- -
-10.97%
Sales/Revenue/Turnover
- -
- -
1.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
75
124
129
116
444
2025
147
102
108
93
450
2026
100
111
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.09
0.15
0.08
0.39
2025
0.13
0.05
0.06
0.03
0.27
2026
0.05
0.04
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.12
2026
- -
- -
- -
- -
- -
Business
SEI Medical Public Company Limited is a Thailand-based distributor and comprehensive service provider of specialized medical devices, healthcare technologies, and scientific laboratory equipment. Founded in 1986 and headquartered in Bangkok, Thailand, the company operates across the domestic healthcare sector, serving public and private hospitals, university medical schools, specialized clinics, and academic research institutions throughout the country. SEI Medical organizes its core commercial offerings into five primary product segments: Endoscopy, comprising gastrointestinal endoscopes, bronchoscopes, otolaryngology instruments, endoscopic video processors, and automated endoscope reprocessing and disinfection systems; Neonatal Patient Care, encompassing infant incubators, infant radiant warmers, neonatal ventilators, phototherapy systems for neonatal hyperbilirubinemia, and non-invasive bilirubin monitors; Surgical Equipment, including operating tables, surgical lighting systems, electrosurgical units, electrocautery devices, and specialized surgical instruments; Aesthetic and Wellness Solutions, featuring non-invasive weight-management devices such as intragastric balloons, skin-tightening platforms, and aesthetic body-contouring technologies; and Scientific Equipment, providing laboratory drying ovens, precision incubators, particle characterization analyzers, and research instruments for chemical and biological analysis. Complementing its product distribution, the company delivers end-to-end technical services, including turnkey equipment installation; comprehensive preventive maintenance, calibration, and engineering repairs; flexible equipment leasing and operating rental solutions; and health-tech integrations, such as artificial intelligence-enabled diagnostic cancer-screening tools and hospital clinical data management systems. In September 2024, SEI Medical completed a significant corporate milestone by listing on Thailand's Market for Alternative Investment (mai) under the ticker symbol SEI through an initial public offering that raised THB 155 million in growth capital. The company is actively deploying these proceeds to procure next-generation medical systems, expand its medical device leasing agreements, grow its recurring maintenance revenue, and introduce high-margin disposable medical supplies and AI-driven clinical software across its national customer base.